Amneal Pharmaceuticals, Inc. - stock earnings
AMRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -98.6 million USD | 617.0 million USD |
| 2023Q3 | 9.7 million USD | 620.0 million USD |
| 2023Q2 | 11.9 million USD | 599.0 million USD |
| 2023Q1 | -10.1 million USD | 557.5 million USD |
| 2022Q4 | -5.9 million USD | 609.8 million USD |
| 2022Q3 | -2.4 million USD | 545.6 million USD |
| 2022Q2 | -240.1 million USD | 559.4 million USD |
| 2022Q1 | -6.5 million USD | 497.6 million USD |
| 2021Q4 | -6.4 million USD | 536.9 million USD |
| 2021Q3 | -4.2 million USD | 528.6 million USD |
| 2021Q2 | 14.5 million USD | 535.1 million USD |
| 2021Q1 | 6.7 million USD | 493.1 million USD |
| 2020Q4 | -3.0 million USD | 510.0 million USD |
| 2020Q3 | -9.0 million USD | 519.3 million USD |
| 2020Q2 | -12.0 million USD | 464.7 million USD |
| 2020Q1 | 115.1 million USD | 498.5 million USD |
| 2019Q4 | -32.1 million USD | 397.3 million USD |
| 2019Q3 | -265.0 million USD | 378.3 million USD |
| 2019Q2 | -16.9 million USD | 404.6 million USD |
| 2019Q1 | -47.9 million USD | 446.1 million USD |
| 2018Q4 | -8.8 million USD | 497.5 million USD |
| 2018Q3 | 7.0 million USD | 476.5 million USD |
| 2018Q2 | -219.4 million USD | 413.8 million USD |
| 2018Q1 | 51.5 million USD | 275.2 million USD |
| 2017Q4 | 61.6 million USD | 293.4 million USD |
| 2017Q3 | 26.8 million USD | 254.7 million USD |
| 2017Q2 | 37.4 million USD | 259.9 million USD |
| 2017Q1 | -65.9 million USD | 254.7 million USD |
| 2016Q4 | 53.9 million USD | 298.6 million USD |
AMRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -84.0 million USD | 2.4 billion USD |
| 2022 | -254.8 million USD | 2.2 billion USD |
| 2021 | 20.2 million USD | 2.1 billion USD |
| 2020 | 68.6 million USD | 2.0 billion USD |
| 2019 | -603.6 million USD | 1.6 billion USD |
| 2018 | -169.7 million USD | 1.7 billion USD |
| 2017 | 167.6 million USD | 1.0 billion USD |
| 2016 | 207.4 million USD | 1.0 billion USD |
| 2015 | 39.0 million USD | 860.5 million USD |
| 2014 | 176.9 million USD | 785.6 million USD |
AMRX
Price: $5.87
52 week price:
Earnings Per Share: -0.48 USD
P/E Ratio: 92
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1.8 million
Market Capitalization: 1.7 billion